MedTrace Logo

Anesthesia and Cancer Recurrence im Malignant Melanoma

NCT01588847 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 230

Last updated 2014-12-11

No results posted yet for this study

Summary

Studies in animals and retrospective studies in humans show that regional anesthesia reduces metastatic cancer dissemination.

The investigators hypothesize that in patients suffering from malignant melanoma who have to undergo radical inguinal lymph node dissection immune function will be less compromised and long term survival will be superior when spinal anesthesia is compared to general anesthesia.

Conditions

  • Malignant Melanoma

Interventions

PROCEDURE

Spinal anesthesia with Bupivacaine hyperbar 0.5 %

Spinal anesthesia with Bupivacaine hyperbar 0.5 %

PROCEDURE

General anesthesia with Sufentanil, Propofol and Rocuronium and Sevoflurane

General anesthesia with Sufentanil, Propofol and Rocuronium and Sevoflurane

Sponsors & Collaborators

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Hugo K Van Aken, MD PhD · University Hospital Muenster, Department of Anesthesia, Intensive Care and Pain Therapy

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2019-03-31
Completion
2019-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01588847 on ClinicalTrials.gov